Applied Genetic Technologies Corp.
(NASDAQ : AGTC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.20%83.100.9%$974.49m
KITEKite Pharma, Inc.
0.03%179.3616.1%$742.33m
CELGCelgene Corporation
0.46%144.551.1%$500.01m
AMGNAmgen Inc.
0.16%186.051.1%$483.92m
BIIBBiogen Inc.
-0.14%318.001.2%$421.75m
REGNRegeneron Pharmaceuticals, Inc.
1.45%439.002.7%$359.48m
ALNYAlnylam Pharmaceuticals, Inc
1.81%115.8610.7%$250.17m
ALXNAlexion Pharmaceuticals, Inc.
0.46%143.481.9%$230.03m
JUNOJuno Therapeutics, Inc.
-4.81%42.9714.6%$225.37m
VRTXVertex Pharmaceuticals Incorporated
-1.38%149.171.9%$208.45m
INCYIncyte Corporation
-1.22%109.502.6%$205.12m
ILMNIllumina, Inc.
-0.63%200.143.5%$158.40m
BLUEBluebird Bio, Inc.
1.17%130.2519.3%$143.09m
BMRNBioMarin Pharmaceutical Inc.
-0.79%94.204.4%$136.30m
CLVSClovis Oncology, Inc.
-2.95%76.2518.0%$132.43m

Company Profile

Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.